2008
DOI: 10.1002/pd.1949
|View full text |Cite
|
Sign up to set email alerts
|

First prenatally diagnosed case of 16p11.2p12.1 duplication

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2012
2012
2015
2015

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…A prenatal case was excluded as no sonographic anomalies were found before termination of the pregnancy. 25 Only developmental and/or psychomotor delay was present in all patients. In one patient and the twins, normal development was followed by a marked decline after the age of 2.…”
Section: Discussionmentioning
confidence: 98%
“…A prenatal case was excluded as no sonographic anomalies were found before termination of the pregnancy. 25 Only developmental and/or psychomotor delay was present in all patients. In one patient and the twins, normal development was followed by a marked decline after the age of 2.…”
Section: Discussionmentioning
confidence: 98%
“…All five genes have been described in conditions that demonstrate disease resulting from haploinsufficiency or loss of function of the gene product, so it is unclear whether triplication of these genes contribute to our patients' phenotypes. Evidence for dosage-sensitive genes in the 16p11.2-12.2 region is supported by previous reports of duplications associated with phenotypes including developmental delay, dysmorphic features, intellectual disability, autism spectrum disorder, microcephaly, short stature, and tapered fingers [Finelli et al, 2004;Behjati et al, 2008;Bourthoumieu et al, 2008;Tabet et al, 2012;Barber et al, 2013].…”
Section: Discussionmentioning
confidence: 70%
“…Of these, the most common is the 550 kb microdeletion at 16p11.2 that is estimated to be present in 1% of patients with autism spectrum disorder (ASD) [Weiss et al, 2008]. Duplications involving 16p11.1p13.1 [Kirchhoff et al, 2005], 16p11.2p12.1 [Engelen et al, 2002;Bourthoumieu et al, 2008], 16p11.2p12.2 [Finelli et al, 2004;Pani et al, 2010;Tabet et al, 2012;Barber et al, 2013], 16p11.2p13.1 [Behjati et al, 2008], 16p12.1p12.2 [Ballif et al, 2007], and 16p12.2 [Marshall et al, 2008;Itsara et al, 2009] have also been reported in association with neurodevelopmental disorders, congenital anomalies, and dysmorphic features, suggesting that a number of dosage-sensitive genes reside in that region. There is a single report of triplication involving 16p12.1 in a patient with intellectual disability, dysmorphic facial features, short stature, and hypotonia [Ballif et al, 2007].…”
Section: Introductionmentioning
confidence: 99%
“…15,16 A 16p11.2p12.2 duplication identified prenatally was also reported. 17 Thus, the phenotype of the 16p11.2p12 duplication is not well defined.…”
Section: Introductionmentioning
confidence: 99%